Dr. Rod Rohrich Has A Busy Schedule This Year

Dr. Rod Rohrich is one of the leading cosmetic surgeons operating int he United States today, working out of the Dallas area in Texas. Rod has a strong academic background with several different degrees under his belt as well as being a professor at the Southwestern Medical School. Rod Rohrich’s incredible results in cosmetic surgery have earned him several prestigious awards in his industry, and it is the reason he has been invited to attend three major conferences in 2018 focused on discussing various topics in the cosmetic industry.

One of the largest symposiums in the country, the Baker Gordon Educational Symposium, is where the first conference will be held on February 8th in Miami. The Baker Gordon Educational Symposium started up decades ago performing live surgery’s, and today it has become one of the largest conferences in the United States. Many discussions are held on the changes that have occurred in the industry over the years as well as what to look forward to in the future. Many other surgeons and innovators in the cosmetic industry will be attending this meeting as well. Dr. Rod Rohrich will be performing a live surgery during this event and act as a moderator for the panel participants.

The second conference Dr. Rod Rohrich will be joining takes place on February 28th and it is the 21st Global Dallas Cosmetic Surgery and Medicine Meeting. Rod Rohrich will be acting as coordinator and chairman at this conference. During this conferences, world-class surgeons will speak on the latest cutting-edge technologies that have come forward that aid in tissue tightening, lasers, vaginal rejuvenation, dermal fillers, and noninvasive procedures. The current ethics in social marketing and patient safety will also be discussed during the conference.

Unlike the first conference into the second, there will be no time to rest proceeding the second meeting. The third conference, the 35th Annual Dallas Rhinoplasty Meeting, is set to start on March 2, ending on the 3rd. Dr. Rod Rohrich will be the chairman of this conference as well as a panel participant. The top surgeons in Rhinoplasty will be attending this last meeting to discuss the problems currently facing the field and the improvements that can be made in the future. Instagram photos

Dr. David Samadi Discusses Prostate Cancer

Summer of 2017 was quite a roller coaster ride for Republican Mitt Romney, he recently revealed he had undergone surgery to remove a tumor that was slowly developing in his prostate. The surgery procedure was performed at the U.C. Irvine Hospital by Dr. Thomas Ahlering. The prognosis for the prostate cancer was deemed positive, it was successfully treated in surgery and the politician might be up and ready for a comeback and become Orrin Hatch’s successor if he plans on running for the U.S. Senate.

According to the The American Cancer Society, 161,360 men were diagnosed with prostate cancer during 2017. They estimated that those numbers could reach close to 164,690 in new cases by the end of 2018. Prostate cancer is a disease known to develop in men over forty years of age, six out of ten cases are diagnosed with the disease around the ages of 65 and up. Mitt Romney wasn’t the first known politician to have been diagnosed with prostate cancer, it happened to Colin Powell in 2013 and John Kerry when he was nominated to run for President. They all have received some form of surgical treatment and currently appear to have no signs of the disease.

Dr. David B. Samadi is a urologist from the Lenox Hill Hospital in New York, N.Y., he thinks the key to their positive outcome was because all of those politicians chose surgery for treatment. When his patients are diagnosed with prostate cancer, the first thing he must carefully decide is what type of treatment is best and weigh the pros and cons to his patients, radiation or surgery?

He states that surgery is highly recommended if the cancer is localized and not spreading past the prostate gland. He favors surgery because there’s a better chance for survival, a patient that chose radiation were twice as likely to die sooner. Radiation treatment could also cause serious side effects such as secondary cancers that develop in the colon, rectal area or bladder.

Dr. David B. Samadi currently serves as the Chairman of Urology and the Chief of Robotic Surgery at the Lenox Hill Hospital. He has performed over 7,000 prostate surgeries via the da Vinci robotic system and is one of the leading prostate surgeons in New York. He received a B.S. degree in Biochemistry at Stony Brook University and earned his M.D. degree from Stony Brook School of Medicine.

Read More: insider.foxnews.com/tag/dr-david-samadi

Securus Technologies Acquires GovPayNet

Securus technologies has confirmed its acquisition of GovPayNet, an industry leader when it comes to processing credit and debit card transactions to government agencies. The acquisition is a strategic move by Securus aimed at expanding the company’s payment servicing business. Being a leader in the technology solutions’ subsector, Securus Technologies is determined to expand its local and international market-share.

 

Established in 1997, GovPayNet already serves more than 2,300 agencies in 35 states in the U.S. The company is a renowned provider of payment processing services relating to court fines, cash bail, and real estate as well as property tax payments. Robert Pickens, the president and CEO of Securus Technologies, has expressed the company’s excitement for the successful acquisition of GovPayNet. Robert further explained that GovPayNet and its leadership, led by Mark Mackenzie, have all the attributes that conform to Securus’ business values.

 

The CEO believes that the acquisition will now enable them to process more than 40 million payments every year. According to him, Securus Technologies now plans to combine its diverse capabilities in order to venture into new segments. GovPayNet’s CEO, Mark Mackenzie, has applauded the deal projecting that his company’s combined effort with JPay and Securus would help grow them grow and venture into new areas.

 

About Securus Technologies

 

Securus Technologies is a technology solutions company based in Carrolton, Texas. Accredited by the Better Business Bureau, the company serves about 3,500 law enforcement, corrections, and public safety agencies. It is also reported that Securus currently serves about 1,200,000 inmates in North America region.

 

Under the leadership of Richard A. Smith as its Chief Executive Officer, Securus has continued to advance its wide range of services including inmate self-service, biometric analysis, information management, emergency response, and government payment services among others. The addition of GovPayNet into its portfolio of products would undoubtedly fuel its growth and expansion.

 

http://www.prnewswire.com/news-releases/securus-technologies-inc-to-acquire-jpay-inc-300065531.html

 

http://www.prnewswire.com/news-releases/securus-receives-accreditation-from-better-business-bureau-300267674.html